E-Coli Testing Market Research, 2033
The global e-coli testing market was valued at $2.1 billion in 2023, and is projected to reach $3.9 billion by 2033, growing at a CAGR of 6.5% from 2024 to 2033. Rise in the incidences of food-borne illnesses, technological advancements, and consumer awareness are the primary drivers of the market.
Market Introduction and Definition
E-coli testing refers to the process of detecting the presence of Escherichia coli (e-coli) bacteria in various samples, such as food, water, clinical specimens, or environmental samples. It is a type of bacteria that is frequently discovered in both human and animal intestines. Many e-coli strains are benign, but some can cause anything from minor gastrointestinal discomfort to serious infections. E-coli testing is done in clinical settings to identify infections brought on by pathogenic strains of the bacteria. Urinary tract infections (UTIs) , sepsis, newborn meningitis, and gastrointestinal illnesses (such diarrhea) are among the common infections. To isolate and identify the bacteria, testing may require cultivating clinical materials such as urine, feces, blood, or cerebrospinal fluid.
Key Takeaways
- The e-coli testing market size study covers 20 countries. The research includes a segment analysis of each country in terms of value for the projected period.
- More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major e-coli testing industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
- The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions in order to achieve their most ambitious growth objectives.
Key Market Dynamics
The global e-coli testing market size is growing due to several factors across various sectors, including food safety, healthcare, environmental monitoring, and research. E-coli testing is becoming more necessary in the food sector due to the increased prevalence of foodborne infections brought on by pathogenic strains of the bacteria. The use of e-coli testing techniques to guarantee the safety of food products is driven by strict food safety laws and rising consumer awareness of foodborne diseases. In addition, global governments and regulatory bodies have enforced strict guidelines and norms pertaining to food safety in order to safeguard the public's well-being and guarantee the security of food distribution networks. Regular testing for foodborne pathogens, such as e-coli, is required in order to comply with these rules, which propels e-coli testing market growth.
Furthermore, the necessity for e-coli testing in water quality monitoring programs is driven by growing worries about waterborne illnesses and the requirement to guarantee the security of drinking water sources. Frequent testing is crucial for identifying and preventing fecal contamination in water sources, as highlighted by government programs, environmental restrictions, and public health campaigns, thereby, increasing e-coli testing market opportunity.
Patient Population
According to the National Center for Biotechnology Information, a global analysis for the incidence of adult e-coli bacteremia in high-income nations is estimated to be 48 cases per 100, 000 person-years, with a case-fatality rate (CFR) of 12.4%. There was a documented rise in incidence after the age of 60, with a peak of 319 per 100, 000 person-years beyond the age of 85. Infections with e-coli can be fatal, also certain studies indicate that approximately 17% of e-coli infections result in mortality. In comparison to other types of e-coli infections, UTIs generally have a lower chance of being lethal.
Incidence of adult E. Coli bacteremia in high-income nations
No of cases | Per Population |
48 | 100,000 |
Market Segmentation
The e-coli testing market analysis is segmented into test, end user, and region. On the basis of test, the market is categorized into environmental test and clinical test. On the basis of end user, the market is classified into hospitals, diagnostic laboratories, and physicians' offices. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Regional/Country Market Outlook
North America accounted for a major of the e-coli testing market share owing to the presence of several major players, robust regulatory frameworks and stringent food safety regulations. With hospitals, clinical laboratories, and research institutes equipped with cutting-edge diagnostic tools, North America has an advanced healthcare infrastructure. Because of the region's cutting-edge healthcare system, e-coli infections are easier to diagnose and treat, which increases demand for diagnostic services and tests, including e-coli testing.
Asia-Pacific e-coli testing market share is estimated to grow at the highest CAGR during the forecast period, owing to certain developing economies for instance China, India are growing and becoming more urbanized, which is driving the demand for clean and safe food items. Cases of foodborne diseases connected to e-coli contamination have increased public awareness and created a need for strict testing guidelines, which has fueled industry expansion.
Moreover, increased testing for infectious diseases, particularly e-coli infections, is a result of improvements in the Asia-Pacific region's healthcare system and availability of diagnostic services. To identify and treat infections linked to e-coli, hospitals, clinical laboratories, and other healthcare facilities invest in diagnostic technology, which drives e-coli testing market forecast.
Industry Trends
- In June 2022, researchers from the Indian Institute of Technology (IIT) Kanpur developed an enzyme-substrate medium-based e-coli water testing kit that is highly sensitive and can detect the presence or absence of a single e-coli in drinking water. Thus, such developments are the e-coli testing market trends.
Competitive Landscape
The major players operating in the e-coli testing industry include Thermo Fisher Scientific Inc., IDEXX Laboratories, Inc., Becton, Dickinson and Company, Meridian Bioscience Inc., Bio-Rad Laboratories, Inc., Alere Inc., CPI International, bioMérieux SA, Pro Lab diagnostics, and Nano Logix Inc.
Recent Key Strategies and Developments
- In June 2021, Bio-Rad Laboratories, Inc. announced that its RAPID'E.coli 2 Agar for water testing received approval from the U.S. Environmental Protection Agency (EPA) for testing drinking water for Escherichia coli (e-coli) and total coliforms. The solution includes chromogenic medium and a selective supplement that can detect these bacteria without the need for a confirmation step.
- In October 2022, The CE-IVD marked TaqPath Enteric Bacterial Select Panel, recently introduced by Thermo Fisher Scientific, detects common gastrointestinal (GI) bacteria, enabling clinicians to quickly identify the root cause of an infection and administer the most appropriate treatment to their patients. The panel was validated and registered under IVD in May. The test uses polymerase chain reaction (PCR) technology to analyze stool samples for a range of common GI bacteria, including e-coli. It can reliably return results in about two hours, with more than 98% sensitivity and specificity, the company reports. This is much faster than culturing samples in a laboratory, which can take up to two weeks to deliver results.
Key Sources Referred
- National Center for Biotechnology Information
- World Health Organization (WHO)
- National Library of Medicine
- The United States Food and Drug Administration
- U.S. Department of Health & Human Services
- Centers for Disease Control and Prevention
- GOV.UK
- U.S. Department of Agriculture
- Provincial Health Services Authority
- Illinois Department of Public Health
- Ministry of Health and Family Welfare Government of India
- U.S. Environmental Protection Agency
- Oregon Department of Veterans Affairs
- Government of South Australia
- Health Canada
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the e-coli testing industry to identify the prevailing market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the e-coli testing market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global e-coli testing market trends, key players, market segments, application areas, and market growth strategies.
E-coli Testing Market Report Highlights
Aspects | Details |
Market Size By 2033 | USD 3.9 Billion |
Growth Rate | CAGR of 6.5% |
Forecast period | 2024 - 2033 |
Report Pages | 240 |
By Test |
|
By End User |
|
By Region |
|
Key Market Players | Becton, Dickinson and Company, IDEXX Laboratories, Inc., Meridian Bioscience Inc., Bio-Rad Laboratories, Inc., CPI International, Nano Logix Inc, bioMérieux SA, Alere Inc., Thermo Fisher Scientific Inc, Pro Lab diagnostics |
Other Players | NanoLogix, Inc. |
Surge in healthcare, and environmental are the upcoming trends of E-coli Testing Market in the globe.
Clinical are the leading test of E-coli Testing Market.
North America is the largest regional market for E-coli Testing.
The global e-coli testing market was valued at $2.1 billion in 2023.
The major players operating in the E. coli testing market include Thermo Fisher Scientific Inc., IDEXX Laboratories, Inc., Becton, Dickinson and Company, Meridian Bioscience Inc., Bio-Rad Laboratories, Inc., Alere Inc., CPI International, bioMérieux SA, Pro Lab diagnostics and Nano Logix Inc.
Loading Table Of Content...